Control of illegal medroxyprogesterone acetate—application in veal calves by residue analysis in adipose tissue using HPLC/RIA methods
Authors:
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Food Additives & Contaminants: Part A
- Vol. 6 (1) , 59-69
Abstract
Procedures for the determination of medroxyprogesterone acetate (MPA) in adipose tissue collected at time of slaughter allowing the control of MPA application to veal calves are described. Screening radioimmunoassays after sample clean‐up were sufficient for a first survey of MPA treatments in livestock herds. Validation of all positive samples was performed by two‐dimensional (silica gel diol phase and RP‐18 phase) HPLC/RIA immunograms. Megestrol acetate and melengestrol acetate with cross‐reactivities of 31% and 0.3% respectively were clearly separated by the RP HPLC. With an absolute detection limit of 4 pg MPA/tube (90% relative binding) negative control samples did not exceed 6 pg/tube, equivalent to 6 pg/g fat in the validating method. Seventeen days after intramuscular (i.m.) injection of 24 mg MPA only 32 pg MPA/g fat were found, while i.m. injection of 60 mg MPA and a waiting period of 19 days resulted in 2700 pg MPA/g fat. After feeding two calves 20 μg MPA per head daily for 1 week followed by 200 μg MPA per head daily for 2 weeks 359 and 468 pg MPA/g fat were measured. In plasma as well as in adipose tissue more than 80% of the whole immunoreactive material was MPA itself, without indications for the presence of cross‐reacting MPA metabolites as confirmed by HPLC/RIA immunograms. Based on day of slaughter ratios of accumulation of MPA from plasma into fat of MPA‐fed veal calves were 52 and 72 respectively. In urine MPA was only detectable a few days after injection; as compared to a plasma concentration of 950 pg MPA/ml the amount in urine was only 37 pg MPA/ml and also 325 pg unidentified MPA‐equivalents/ml.Keywords
This publication has 12 references indexed in Scilit:
- Development of a sensitive microtitration plate enzyme‐immunoassay for the anabolic steroid trenboloneFood Additives & Contaminants: Part A, 1987
- Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjectsJournal of Pharmaceutical and Biomedical Analysis, 1983
- Determination of medroxyprogesterone acetate in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Plasma levels of progesterone, Provera, oestradiol-17β, and 13,14-dihydro-15-keto-prostaglandin F in cows treated with Provera-impregnated intravaginal spongesReproduction, 1979
- Glucocorticoids in Mammary Secretions and Blood Serum during Reproduction and Lactation and Distributions of Glucocorticoids, Progesterone, and Estrogens in Fractions of MilkJournal of Dairy Science, 1978
- A radioimmunoassay for serum medroxyprogesterone acetateThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginallyContraception, 1976
- Radioimmunoassay for medroxyprogesterone acetate (Provera®) using the 11α-hydroxy succinyl conjugateSteroids, 1974
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1The Journal of Clinical Endocrinology & Metabolism, 1971